Header Social Media

Main navigation

Newsletter of the Myasthenia Gravis Rare Disease Network

Summer 2024 | Jul 2024

MGNet Newsletter Consortium Updates

Learn More

Jun 2023 | Issue No. Summer 2023 | MGNet Newsletter Consortium Updates

Aug 2022 | Issue No. Summer 2022 | MGNet Consortium Updates

Mar 2022 | Issue No. Winter 2022 | MGNet Newsletter Consortium Updates

Nov 2021 | Issue No. Fall 2021 | MGNet Newsletter Program Updates

Aug 2021 | Issue No. Summer 2021 | MGNet Newsletter Consortium Updates

Feb 2021 | Issue No. Winter 2021 | MGNet Newsletter Consortium Updates

Jul 2020 | Issue No. Summer 2020 | MGNet Newsletter Consortium Updates

Mar 2020 | Issue No. Winter 2020 | MGNet Newsletter Consortium Updates

The Myasthenia Gravis Rare Disease Network (MGNet) is part of the Rare Diseases Clinical Research Network (RDCRN), which is funded by the National Institutes of Health (NIH) and led by the National Center for Advancing Translational Sciences (NCATS) through its Division of Rare Diseases Research Innovation (DRDRI). MGNet is funded under grant number U54NS115054 as a collaboration between NCATS and the National Institute of Neurological Disorders and Stroke (NINDS). This website is hosted by the network's Data Management and Coordinating Center at Cincinnati Children’s Hospital Medical Center, which is funded by NCATS and NINDS under grant number TR002818. The content of this website is solely the responsibility of the MGNet administrative coordinating center at George Washington University and does not necessarily represent the official views of the NIH.